Educational Video The Path to Approval

The Center for Biosimilars, Proposed CMS Changes Are the Wrong Way to Save Money and Will Harm Patients and Providers

Non-Medical Switching Principles and Guidelines

Updated Handbook The Biosimilar Promise: An Introduction for Prescribers

Biologics Prescribers Collaborative to Speak at FDA Hearing on Biosimilars

About the Biologics Prescribers Collaborative

The Biologics Prescribers Collaborative aims to ensure that sound policies are in place to promote the safest possible use of all biologics, including biosimilars, for all patients.

Learn More About Us

Member Organizations

Co-conveners

Dennis R. Cryer, MD

Dennis R. Cryer, MD

Genetics and Metabolism, Washington, DC

Gregory Schimizzi, MD

Gregory Schimizzi, MD

Rheumatology, Wilmington, NC

David Charles, MD

David Charles, MD

AfPA National Chairman Neurology, Nashville, TN

Arturo Loaiza-Bonilla, MD

Arturo Loaiza-Bonilla, MD

Oncology, Philadelphia, PA

Rolf Benirschke

Rolf Benirschke

Patient Advocate, San Diego, CA